B-raf Antibody | catalog# 5777
Background
B-raf belongs to the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. The Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt pathways interact with each other to regulate growth and in some cases tumorigenesis. Mutations in B-raf have been associated with several cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung, leading to speculation on the possibility of B-raf as a therapeutic target for treating cancers. Mutations in this gene have also been associated with cardiofaciocutaneous syndrome (CFCS), a disease characterized by heart defects, mental retardation and a distinctive facial appearance.
Description

Specifications
Additional Names
v-raf murine sarcoma viral oncogene homolog B1, proto-oncogene B-raf, p94Disclaimer
This product is for research use only.Formulation
Physical State: LiquidConcentration: 1 mg/mL
Immunogen
B-raf antibody was raised against an 18 amino acid peptide near the center of human B-raf.Clonality/Clone
This is a polyclonal antibody.Purification
Affinity chromatography purified via peptide columnHost
B-raf antibody was raised in chicken.Please use anti-chicken secondary antibodies.
Application
B-raf antibody can be used for detection of B-raf by Western blot at 1 - 2 μg/ml.Tested Application
E, WBBuffer
Antibody is supplied in PBS containing 0.02% sodium azide.Blocking Peptide
Cat.No. 5777P - B-raf PeptideStorage
B-raf antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.Positive Control
- Cat. No. 1303 - Human Brain Tissue Lysate]
Species Reactivity
H, M, RProtein GI Number
50403720Protein Accession Number
P15056Reference
- McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the RAF/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta2007; 1773:1263-84.
- Madhunapantula SV and Robertson GP. Is B-raf a good therapeutic target for melanoma and other malignancies? Cancer Res.2008; 68:5-8.
- Sarkozy A, Carta C, Moretti S, et al. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum. Mutat.2009; 30:695-702.]

